Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-06-22 00:00:00 ET · period of report 2023-06-20 · accession 0001610717-23-000192 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-22 | 2023-06-20 | RVMD | Cislini Jeff | GC | S - Sale | $25.14 | -1,239 | 44.7K | -3% | -$31.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-20 | S | D | 1,239 | $25.14 | 44,727 | D | — | — | (F2) Includes 370 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023. (F3) Includes 38,305 RSUs. |